New chemotherapeutic agents in non-small-cell lung cancer.
Feigal
E G
EG
Clinical Investigations Branch, National Cancer Institute, Bethesda, MD 20892.
Christian
M
M
Cheson
B
B
Grever
M
M
Friedman
M A
MA
D000630:Aminopterin / Q000031:analogs & derivatives / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use; D002166:Camptothecin / Q000031:analogs & derivatives / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D015195:Drug Design; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D000077146:Irinotecan; D008175:Lung Neoplasms / Q000188:drug therapy*; D017239:Paclitaxel / Q000627:therapeutic use; D019772:Topotecan; D014747:Vinblastine / Q000031:analogs & derivatives / Q000627:therapeutic use; D000077235:Vinorelbine
D000970:Antineoplastic Agents; D000972:Antineoplastic Agents, Phytogenic; D014747:Vinblastine; D000077146:Irinotecan; D019772:Topotecan; D007372:Interferons; C040210:edatrexate; D000630:Aminopterin; D017239:Paclitaxel; D000077235:Vinorelbine; D002166:Camptothecin